Teva intends to use proceeds from the anticipated offering, which is subject to market conditions, to finance maturing debt, the Israel-based company said on Sunday.
Teva did not provide further details.
(Reporting by Tova Cohen; Editing by Mark Potter)
Copyright 2013 mojeNovosti.com
web developer: BTGcms